• Home
  • Gabriela Khazanov
Gabriela Khazanov

Gabriela Khazanov
Philadelphia VA Medical Center · Center of Excellence in Substance Addiction Treatment and Education (CESATE)

Doctor of Philosophy

About

27
Publications
3,147
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
497
Citations
Introduction
Gabi has a Ph.D. in clinical psychology from the University of Pennsylvania. She is a Research Psychologist at the Center of Excellence in Substance Addiction Treatment and Education (CESATE) at the Philadelphia VA Medical Center. Her research focuses on improving individuals' engagement in evidence-based therapies for suicide and substance use, with a particular interest in the use of financial and social incentives and in increasing access to and engagement in lethal means safety counseling.
Additional affiliations
September 2019 - present
Philadelphia Veterans Affairs Medical Center
Position
  • PostDoc Position
August 2018 - August 2019
Philadelphia Veterans Affairs Medical Center
Position
  • Clinical Psychology Intern
September 2012 - June 2018
University of Pennsylvania
Position
  • PhD Student

Publications

Publications (27)
Article
Objective: Engagement in mental health treatment is low, which can lead to poor outcomes. We evaluated the efficacy of offering patients financial incentives to increase their mental health treatment engagement, also referred to as contingency management. Method: We meta-analyzed studies offering financial incentives for mental health treatment...
Article
Context Palliative care consultations (PCCs) are associated with reduced physical and psychological symptoms that are related to suicide risk. Little is known, however, about the association between PCCs and death from suicide among patients at high risk of short-term mortality. Objective To examine the association between the number of PCCs and d...
Article
Background: This PRISMA scoping review explored worldwide research on the delivery of suicide-specific interventions through an exclusive telehealth modality. Research over telehealth modalities with suicidal individuals highlights the importance of facilitating participants' access to treatments despite location and circumstances (e.g., rural, ex...
Article
Anhedonia, or reward system dysfunction, is associated with poorer treatment outcomes among depressed individuals. The role of anhedonia in treatment engagement, however, has not yet been explored. We review research on components of reward functioning impaired in depression, including effort valuation, reward anticipation, initial responsiveness,...
Article
Full-text available
Although up to a third of trainees in doctoral programs are parents, research and policy efforts have focused on supporting faculty members much more than trainees. Graduate student parents (GSPs) in professional psychology programs face unique challenges because of their simultaneous research and clinical training, but only a few qualitative studi...
Article
Individuals with psychiatric disorders often struggle to initiate and engage in treatment. Financial incentives improve treatment engagement, including treatment attendance, medication adherence, and abstinence from substance use. The U.S. Department of Veterans Affairs (VA) recently made the first large-scale, successful effort to implement incent...
Article
Background Pharmacogenomic testing has emerged to aid medication selection for patients with major depressive disorder (MDD) by identifying potential gene-drug interactions (GDI). Many pharmacogenomic tests are available with varying levels of supporting evidence, including direct-to-consumer and physician-ordered tests. We retrospectively evaluate...
Article
Background: Psychotherapy for depression and antidepressant medications have both been associated with decreases in suicidal ideation. Studies have not examined whether adding psychotherapy to antidepressant medications further reduces suicidal ideation relative to medications alone in adults. Methods: Participants (N = 452) were randomized to 7...
Article
Two core features of depression include depressed mood (heightened distress) and anhedonia (reduced pleasure). Despite their centrality to depression, studies have not examined their contribution to treatment outcomes in a randomized clinical trial providing mainstream treatments like antidepressant medications (ADM) and cognitive therapy (CT). We...
Article
The cardinal symptoms of Major Depressive Disorder (MDD) are heightened depressed mood (negative affectivity; NA) and diminished interest or pleasure (positive affectivity; PA). It is unknown how well treatments for MDD repair each. Two secondary analyses of randomized controlled trials were therefore conducted. In Study One, 180 adult depressed ou...
Article
Full-text available
We present the Positive Valence Systems Scale (PVSS), a measure of the National Institute of Mental Health’s Research Domain Criteria Positive Valence Systems domain. An initial long form of the scale (45 items) providing a broad assessment of the domain was distilled into a short form (21 items) measuring responses to a wide range of rewards (Food...
Article
Depressed individuals show altered responding to positive events relative to healthy individuals. This altered responding predicts greater symptom severity and functional impairment, and is not adequately addressed in current treatments. The present research aimed to utilize recent advances in the field to develop a more sophisticated understanding...
Article
Depressed individuals are less reactive than healthy individuals to positive stimuli in the laboratory, but accumulating evidence suggests that they are more emotionally reactive to positive events in their daily lives. The present study probed the boundaries of this curious “mood brightening” effect and investigated its specificity to major depres...
Chapter
Anxiety and depressive disorders frequently co-occur, yet the reasons for their comorbidity are poorly understood. This chapter reviews patterns of comorbidity between DSM-IV-defined anxiety disorders and major depression, including estimates derived for this chapter from the National Comorbidity Survey Replication (NCS-R). Next, nearly a dozen can...
Article
Full-text available
Depression is well known to share a negative cross-sectional relationship with personality constructs defined by positive emotion (positive affect, extraversion, behavioral activation). These Positive Emotionality (PE) constructs have been proposed to represent stable temperamental risk factors for depression, not merely current mood state. These c...
Article
Full-text available
Despite growing evidence that bipolar disorder often emerges in adolescence, there are limited data regarding treatment patterns of youth with bipolar disorder in community samples. Our objective was to present the prevalence and clinical correlates of treatment utilization for a nationally representative sample of US adolescents with bipolar disor...
Article
Full-text available
Investigators have proposed the diagnostic value of a generalized subtype of specific phobia, with classification based upon the number of phobic fears. However, current and future typologies of specific phobia classify the condition by the nature of phobic fears. This study investigated the clinical relevance of these alternative typologies by: (1...
Article
Full-text available
Context: There are limited data on the manifestations of mania in general community samples of adolescents. Objective: To present the prevalence and clinical correlates of mania with and without depressive episodes in a representative sample of US adolescents. Design: Cross-sectional survey of adolescents using a modified version of the Compos...
Article
Social phobia typically develops during the adolescent years, yet no nationally representative studies in the United States have examined the rates and features of this condition among youth in this age range. The objectives of this investigation were to: (1) present the lifetime prevalence, sociodemographic and clinical correlates, and comorbidity...

Network

Cited By